XR Securities’s Pfizer PFE Stock Holding History

XR Securities’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-7,794	Closed	-$227K	–	217
2024 Q2	$218K	Buy	+7,794	New	+$215K	0.04%	224
2024 Q1	–	Sell	-19,121	Closed	-$531K	–	421
2023 Q4	$550K	Buy	+19,121	New	+$578K	0.02%	253
2022 Q4	–	Sell	-8,165	Closed	-$391K	–	553
2022 Q3	$357K	Buy	+8,165	New	+$397K	0.19%	95
2022 Q2	–	Sell	-6,320	Closed	-$322K	–	454
2022 Q1	$327K	Buy	+6,320	New	+$328K	0.06%	109
2021 Q4	–	Sell	-15,531	Closed	-$770K	–	507
2021 Q3	$668K	Buy	15,531 +2,640	+20%	+$117K	0.31%	69
2021 Q2	$505K	Sell	12,891 -24,630	-66%	-$958K	0.22%	80
2021 Q1	$1.36M	Buy	+37,521	New	+$1.33M	0.08%	35
2020 Q4	–	Sell	-17,457	Closed	-$640K	–	471
2020 Q3	$608K	Buy	17,457 +8,599	+97%	+$301K	0.05%	43
2020 Q2	$275K	Buy	+8,858	New	+$301K	0.03%	104

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

XR Securities's PFE Position: Q3 2024 in Review

XR Securities sold out of Pfizer (PFE) in Q3 2024, closing a stake of 7,794 shares — an estimated $227K sold.

XR Securities first reported a position in PFE in Q2 2020 and held it in 9 quarters. The position peaked at $1.36M in Q1 2021. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

XR Securities reported no remaining Pfizer position as of Q3 2024 after selling out during the quarter.
XR Securities sold 7,794 Pfizer shares in Q3 2024, an estimated $227K.
XR Securities first reported a position in Pfizer in Q2 2020 and held it in 9 quarters.
XR Securities's Pfizer position peaked at $1.36M in Q1 2021.
2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on XR Securities's 13F filing for Q3 2024, filed 25 Oct 2024.